Rouf Adeel

Director at Zalatoris Acquisition Corp. · on record since Oct 18, 2023
Director at Zalatoris II Acquisition Corp · on record since Nov 3, 2023
Director at Voyager Acquisition Corp./Cayman Islands · on record since Aug 15, 2024
Chief Executive Officer at Voyager Acquisition Corp./Cayman Islands · on record since Aug 15, 2024
10% owner at Voyager Acquisition Corp./Cayman Islands · on record since Aug 15, 2024
Director at Titan Acquisition Corp. · on record since Apr 11, 2025
Chief Financial Officer at Titan Acquisition Corp. · on record since Apr 11, 2025
10% owner at Titan Acquisition Corp. · on record since Apr 11, 2025
See Remarks at Altus Pharmaceuticals Inc. · on record since Dec 8, 2020

Insider trading activity of Rouf Adeel

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Titan Acquisition Corp.Listing unverified	Apr 11, 2025	BuyD (derivative)	5,710,056	1.00 USD	$5.7M	Cluster	SEC
Voyager Acquisition Corp./Cayman IslandsListing unverified	Aug 15, 2024	BuyD (derivative)	5,037,500	1.00 USD	$5M	First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Titan Acquisition Corp.Listing unverified	Apr 11, 2025	BuyD (derivative)	5,710,056	1.00 USD	$5.7M	Cluster	SEC
Voyager Acquisition Corp./Cayman IslandsListing unverified	Aug 15, 2024	BuyD (derivative)	5,037,500	1.00 USD	$5M	First in 12mo	SEC